PTPIP51 crosslinks the NFκB signaling and the MAPK pathway in SKBR3 cells

Future Science OA
Eric DietelMonika Wimmer

Abstract

PTPIP51 interacts with NFκB signaling at the RelA and IκB level. NFκB signaling is linked to the initiation, progression and metastasis of breast cancer. Her2-amplified breast cancer cells frequently display activation of the NFκB signaling. We aimed to clarify the effects of NFκB inhibition on the NFκB- and MAPK-related interactome of PTPIP51 and cell viability in HaCat cells and SKBR3 cells. IKK-16 selectively reduced cell viability in SKBR3 cells. PDTC induced a formation of the Raf1/14-3-3/PTPIP51 complex in SKBR3 cells, indicating a shift of PTPIP51 into MAPK signaling. IKK-16 selectively inhibits cell viability of SKBR3 cells. In addition, PTPIP51 might serve as the mediator between NFκB signaling and the MAPK pathway in SKBR3.

References

Oct 3, 2002·Nature Reviews. Immunology·Qiutang Li, Inder M Verma
Jul 4, 2003·The EMBO Journal·Makio HayakawaKiyomi Kikugawa
Feb 3, 2004·Oncogene·Thomas D GilmoreDaniel T Starczynowski
Oct 21, 2005·Bioorganic & Medicinal Chemistry Letters·Rudolf WaelchliAchim Schlapbach
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas A BuchholzAysegul A Sahin
May 9, 2008·Molecular & Cellular Proteomics : MCP·Yu XueXuebiao Yao
Apr 28, 2010·Gastroenterology·Janos TerzićMichael Karin
May 25, 2010·Biochimica Et Biophysica Acta·Subash C GuptaBharat B Aggarwal
Mar 4, 2011·Cell and Tissue Research·Alexander BrobeilMonika Wimmer
Mar 23, 2012·Immunological Reviews·Fei LiuInder M Verma
May 1, 2012·Cell Biochemistry and Biophysics·Alexander BrobeilMonika Wimmer
Sep 5, 2014·Cancer Immunology Research·Yifeng XiaInder M Verma
Apr 22, 2015·Biomolecules·Alexander BrobeilMonika Wimmer
Jan 21, 2017·PloS One·Bruno R B PiresEliana S F W Abdelhay

❮ Previous
Next ❯

Methods Mentioned

BETA
proximity ligation
proximity ligation assay
ELISA

Software Mentioned

GPS
DuoLink Image Tool

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.